Vericel Corp Ord (VCEL)
- Exchange
- NASDAQ
- Symbol
- VCEL
- Sector
- Life Sciences
- Industry
- Biological Products, (no Disgnostic Substances)
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care markets in the United States. The company is headquartered in Cambridge, Massachusetts.
- Country
- USA
Stock price
At close: November 5, 2024
-
Open44.32
-
High45.66
-
Low43.81
-
Close44.75
-
Volume523,796
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
4.73
Receivables turnover
3.74
Payables turnover
2.77
Working capital turnover
1.24
Days of inventory on hand (DOH)
77.12
Days of sales outstanding (DSO)
97.49
Number of days of payables
131.69
Fixed asset turnover
4.74
Total asset turnover
0.56
Current ratio
4.49
Quick ratio
3.55
Cash ratio
2.39
Cash conversion cycle
42.92
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.57
Interest coverage
-6.14
Gross profit margin
68.64%
Operating profit margin
-3.27%
Pretax margin
-1.20%
Net profit margin
-1.61%
Operating return on assets (Operating ROA)
-1.83%
Return on assets (ROA)
-0.90%
Return on total capital
-1.63%
Return on equity (ROE)
-1.41%